Probuphine Implants
Helping You Get Control Of Your Opioid Dependance
Probuphine has the unique benefits of a six-month implant compared to other forms of buprenorphine. It provides the possibility of improved patient convenience from not needing to take medication on a daily basis.
Probuphine is the first buprenorphine implant for the maintenance treatment of opioid dependence. it is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable on low-to-moderate doses of other forms of buprenorphine, as part of a complete treatment program. |
Approved by the US Food & Drug Administration |
Probuphine should be used as part of a complete treatment program that includes counseling and psychosocial support. Probuphine consists of four, one-inch-long rods that are implanted under the skin on the inside of the upper arm and provide treatment for six months. Administering Probuphine requires specific training because it must be surgically inserted and removed. Only a health care provider who has completed the training and become certified through a restricted program called the Probuphine Risk Evaluation and Mitigation Strategy (REMS) program should insert and remove the implants. If further treatment is needed, new implants may be inserted in the opposite arm for one additional course of treatment. The FDA is requiring postmarketing studies to establish the safety and feasibility of placing the Probuphine implants for additional courses of treatment.
|
The most common side effects from treatment with Probuphine include implant-site pain, itching, and redness, as well as headache, depression, constipation, nausea, vomiting, back pain, toothache and oropharyngeal pain. The safety and efficacy of Probuphine have not been established in children or adolescents less than 16 years of age. Clinical studies of Probuphine did not include participants over the age of 65 If further treatment is needed, new implants may be inserted in the opposite arm for one additional course of treatment. The FDA is requiring postmarketing studies to establish the safety and feasibility of placing the Probuphine implants for additional courses of treatment. As part of the program, Probuphine can only be prescribed and dispensed by health care providers who are certified with the REMS program and have completed live training, among other requirements.
|
Appointment Request |
Contact Us
|
What To ExpectGreat Information for first time patients and parents.
|
BlogGet up to date with the latest from our office.
|
FAQ'sAnswers to question or concerns you may have.
|
Navigation |
ConnectShare This Page |
Contact UsDeSanto Clinics
18800 Main St. Suite 204 Huntington Beach CA 92648 Phone: (949) 432-0918 [email protected] |
LocationWebsite by TherapyPrime
|